1
Participants
Start Date
June 30, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Carvedilol immediate release only
All dosages of carvedilol immediate release
Carvedilol extended release only
All dosages of carvedilol extended release
Long acting β-blockers
All dosages of LA propranolol and SA metoprolol
Other α1/β-adrenergic antagonists
i.e., labetalol. All dosages. Excluding carvedilol immediate release and carvedilol extended release.
Short acting Non-selective β-blockers and short acting β1-Selective agents
All dosages of short acting non-selective β-Blockers (Carteolol, Levobunolol, Metipranolol, Nadolol, Penbutolol, Pindolol, Sotalol, Timolol) and short acting β1-Selective agents (Acebutolol, Atenolol, Betaxolol, Bisoprolol, Nebivolol)
No β-blocker
No β-blocker within the month prior to the index date
Lead Sponsor
GlaxoSmithKline
INDUSTRY